PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

The purpose of the present invention is to provide a compound having an excellent CDK4/6 inhibiting activity. The present invention is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof. Un objeto de la presente invención consiste en proporcionar un compuesto...

Full description

Saved in:
Bibliographic Details
Main Authors Tomohiro SHIMADA, Gen UNOKI, Kunio MINAMIZONO, Takuya YOKOSAKA, Yuri SAKAI, Masaru EBISAWA, Akinobu MARUYAMA, Susumu TAKEUCHI, Kyohei HORIE, Hiroshi TAKAHASHI, Kosuke SASAKI, Junji IGARASHI, Tsuyoshi MIZUNO
Format Patent
LanguageEnglish
Spanish
Published 19.02.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The purpose of the present invention is to provide a compound having an excellent CDK4/6 inhibiting activity. The present invention is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof. Un objeto de la presente invención consiste en proporcionar un compuesto que exhibe una actividad inhibitoria de CDK4/6 superior. La presente invención provee un compuesto representado por la Fórmula (I): (ver Fórmula) o una sal farmacéuticamente aceptable de dicho compuesto.
AbstractList The purpose of the present invention is to provide a compound having an excellent CDK4/6 inhibiting activity. The present invention is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof. Un objeto de la presente invención consiste en proporcionar un compuesto que exhibe una actividad inhibitoria de CDK4/6 superior. La presente invención provee un compuesto representado por la Fórmula (I): (ver Fórmula) o una sal farmacéuticamente aceptable de dicho compuesto.
Author Masaru EBISAWA
Tomohiro SHIMADA
Gen UNOKI
Akinobu MARUYAMA
Junji IGARASHI
Tsuyoshi MIZUNO
Kosuke SASAKI
Kyohei HORIE
Yuri SAKAI
Takuya YOKOSAKA
Susumu TAKEUCHI
Kunio MINAMIZONO
Hiroshi TAKAHASHI
Author_xml – fullname: Tomohiro SHIMADA
– fullname: Gen UNOKI
– fullname: Kunio MINAMIZONO
– fullname: Takuya YOKOSAKA
– fullname: Yuri SAKAI
– fullname: Masaru EBISAWA
– fullname: Akinobu MARUYAMA
– fullname: Susumu TAKEUCHI
– fullname: Kyohei HORIE
– fullname: Hiroshi TAKAHASHI
– fullname: Kosuke SASAKI
– fullname: Junji IGARASHI
– fullname: Tsuyoshi MIZUNO
BookMark eNrjYmDJy89L5WTwD4gM8nTxjzbWMdFNiQVxfD1dPP1cFVxcgzzDHEM8w1wVHP1cFAI8HIN8HZ1dQ0M8nR19fCIVHJ2dXQNCHJ18XBWCHX1CFEI8XINc_d14GFjTEnOKU3mhNDeDkptriLOHbmpBfnxqcUFicmpeakm8b4SRgaG5gaGpkbm5ozFRigAIRzFe
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DERIVADO DE PIRIDO[3,4-D]PIRIMIDINA Y SAL FARMACEUTICAMENTE ACEPTABLE DE ESTE.
ExternalDocumentID MX2017015277A
GroupedDBID EVB
ID FETCH-epo_espacenet_MX2017015277A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:47:53 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MX2017015277A3
Notes Application Number: MX20170015277
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180219&DB=EPODOC&CC=MX&NR=2017015277A
ParticipantIDs epo_espacenet_MX2017015277A
PublicationCentury 2000
PublicationDate 20180219
PublicationDateYYYYMMDD 2018-02-19
PublicationDate_xml – month: 02
  year: 2018
  text: 20180219
  day: 19
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies TEIJIN PHARMA LIMITED
RelatedCompanies_xml – name: TEIJIN PHARMA LIMITED
Score 2.9916103
Snippet The purpose of the present invention is to provide a compound having an excellent CDK4/6 inhibiting activity. The present invention is a compound represented...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180219&DB=EPODOC&locale=&CC=MX&NR=2017015277A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6JOpYjsyeJqv9aHIVmS0sr6Qc1Gh4yxbh2IsA1X8d_3Ujbd08hLkoMjOfjlPpLcATzoaHQbaCirhiNLmFljhJQ5NVVpjMzGZsuxyoBbEFpez3hNzbQCn5u_MGWe0J8yOSIiaoJ4L8rzevkfxGLl28rVU_aBU4sXV7RZY-0dy3RmiEDWafM4YhFtUNoO0kaYSJrdlCVcbbIH-2hH2xIOvN-R31KW2zrFPYGDGNnNi1Oo5KsaHNFN6bUaHAbrG2_srsG3OoMoHiQ-i971R0OdDuUg8JkfcoWhM9Ynwu9zhYRMiT2SBITynpC5DroDhVDKY0E6Xa68ka5QhMcTHrnncO9yQT0VVzb6k8MoSLd2oV9Adb6Y55egaDPbaenNiWFh07Qsa6FaMjNdy8e6Pn2eXEF9B6PrndQ6HEuxynfKmnMD1eLrO79FNVxkd6X4fgEGaoMI
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTkWdH0VkTxZX-7U-DMmSlFabttRsdIiMdetAhG24iv--Sdl0TyMvSQ6O5OCX-0hyB3CnC6PbEIayajiyhJk1EpAyJ6YqjZHpyGw7VhlwY6Hl9Yzn1Ewr8Ln-C1PmCf0pkyMKRI0F3ovyvF78B7FI-bZy-ZB9iKn5k8s7pLnyjmU6M4FA0u3QOCIRbmLcYWkzTCTNbskSrjbagV1hY9sSDrTfld9SFps6xT2EvViwmxVHUMmXdajhdem1Ouyz1Y236K7AtzyGKB4kPone9HtDnbzLAfOJH1KFCGesj7jfpwoKiRJ7KGEI0x6XuQ6CgYIwpjFH3YAqryjgCvdoQiP3BG5dyrGnipUN_-QwZOnGLvRTqM7ms_wMFG1qO229NTYs0TQty9pCLZmZruUjXZ88js-hsYXRxVbqDdQ8zoJh4IcvDTiQIpZvljXnEqrF13d-JVRykV2XovwFV5WF-w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRIDO%5B3%2C4-d%5DPYRIMIDINE+DERIVATIVE+AND+PHARMACEUTICALLY+ACCEPTABLE+SALT+THEREOF&rft.inventor=Tomohiro+SHIMADA&rft.inventor=Gen+UNOKI&rft.inventor=Kunio+MINAMIZONO&rft.inventor=Takuya+YOKOSAKA&rft.inventor=Yuri+SAKAI&rft.inventor=Masaru+EBISAWA&rft.inventor=Akinobu+MARUYAMA&rft.inventor=Susumu+TAKEUCHI&rft.inventor=Kyohei+HORIE&rft.inventor=Hiroshi+TAKAHASHI&rft.inventor=Kosuke+SASAKI&rft.inventor=Junji+IGARASHI&rft.inventor=Tsuyoshi+MIZUNO&rft.date=2018-02-19&rft.externalDBID=A&rft.externalDocID=MX2017015277A